Pill for Weight Loss Acomplia Significantly Reduces Visceral Fat

A multi center study which was carried out in Japan resulted out that pill for weight loss Acomplia significantly reduces human visceral fat which is the more dangerous kind of abdominal fat.

The report of direct evidence of the role of rimonabant in reducing the metabolically active fat was presented at the annual meeting of the European Association for the Study of Diabetes.

Taranabant Nears End of Major Study

Merck , the rival of Sanofi-Aventis who are the developer of Taranabant are doing a two year study .The study has reached in its final month of the total time with 2,400 paticipants.

The approval of diet drug taranabant to the market in the United States is expected in spring 2008.

There is no significance of interim results of the trial to scientific meetings.

The expectation of approval of pill for weight loss, rimonabant ended as FDA continuously delayed action and sanofi finally dropped its application in June. The FDA advisory did not recommend the diet drug in the market of United States of America because of the safety issue.

Taranabant is passing through the clinical process quietly which began many years behind rimonabant. In fall 2005 the participants were enrolled for the phase -3 trials which will be completed in the early 2008.

It is expected to come the final result of this trial until spring in which the participants were rerandomized for the second year to find out dose to keep off weight lost in the first.

The interim trial results may be provided by the Merck may bring in notice that it is more exciting diet aid than rimonabant.

Fat Toddlers Suffering Iron Deficiency

The first study which pointed out first link between obesity and iron levels in the children ages 1to 3. It is found in the research that the 20 percent of obese toddlers have deficiency of iron which is an alarming high rate.

The deficiency of iron can cause anemia as the amount of oxygen carried by the blood through body is reduced.

To let toddlers drink cow’s milk and juice containing less iron causes the problem of deficiency of iron which results in to obesity. What is inside the bottle of your child is the future of your child.

The researchers also pointed out that the children who are attended by the day care centers have less iron deficiency as compared to those who don’t take day care services.

Acomplia diet pill at Indian pharmacies

Indian media pointed out that copies of acomplia diet pill are being sold at Indian pharmacies .The pill for weight loss can be obatained for as little as $3.60 for a month.

In May a half-dozen top respected pharmaceutical companies which includes Ranbaxy and Cipla had received an approval from Indian regulatory authorities to sell their own versions of rimonabant.

Acomplia/Zimulti which is developed by Sanofi-Aventis has been approved for sale in India in May but Sanofi-Aventis didn’t put acomplia diet pill in Indian market. Acomplia which is not approved for sale in United States but is sold in Europe for more than $100 per month.

The generic rimonabant which is sold in Indian market is entirely legal in India. The reverse-engineered version of acomplia which was patented before 1995 is permitted for sale in India but sale of this Indian version would not be legal in U.S., Europe or Canada.

The doctor says the overdosing of the acomplia diet pill and taken inappropriately may be harmful for the obese people.

Early sale of Diet pills for weight loss acomplia in United States is a little hope

In Europe the number of obese and overweight patients who takes diet pills for weight loss acomplia is more than 200,000 . The remaining handful of the patients live in other countries of the world. Sanofi-Aventis didn’t give no significance of approval for early sale in the United States.

FDA gives the signal of talking to Sanofi regarding the approval of Zimulti in United States as soon as the completion of additional data confirming the benefit risk profile of best pill for weight loss acomplia .

Acomplia, Diet pills for weight loss which has been approved in the European countries with a strong warning which can be helpful for FDA for the approval of it in United States.

Diet pills for weight loss acomplia will be in U.S Market

Sanofi-Aventis is still hopeful that Acomplia deit pill will be made available in the U.S. market after the approval by the U.S. Food and Drug Administration.
The chapter of acomplia in the U.S.market still is not closed for the Sanofi-Aventis.
Last month Sanofi pulled its application for the approval of Acomplia Diet Pill in the U.S. market . The FDA had voted against the approval of it by taking in consideration the issue of depression and suicidal thoughts as a side effect of acomplia weight loss pill.

A lot of time is lost in America which will be resulted in a profitable cost. The analyst had estimated that the acomplia weight loss pill could be a $5 billion drug and with out U.S market it is estimated that the diet pill for weight loss acomplia has total sales of more than $500 million worldwide.

Walking: A Solution For Many Diseases

There are many exercises and various yoga programs which are enough to confuse any body that which one to adopt to keep your body fit and your health fine. Mayo Physician favors that walking is the one of the best exercise for any of the blood pressure, diabetes, cardiovascular disease, joint problems or mental health problem.

The study which was undertaken by physicians from the Shinshu University Graduate School of Medicine in Matsumoto, Japan pointed out that walking may protect against high blood pressure and decreased muscle strength among older people.